Uro-oncology (bladder, prostate, testicular and kidney cancer)
Current NHS post
Consultant Medical Oncologist, Oxford University Hospitals NHS Trust
Chemotherapy and biological therapy for inpatients and outpatients. Clinical trials.
MB BS FRCP PhD
- American Society of Clinical Oncology.
- British Medical Association.
- Association of Clinical Pathologists.
- British Association for Cancer Research.
- The British Society for Immunology.
- Medical Protection Society.
Dr Andrew Protheroe is a Medical Oncologist within the University of Oxford department of Oncology at the Oxford Cancer and Haematology Centre. He has specialised in Urological Oncology since 2001. He trained at St Thomas’s Hospital in London and after general medical training in London, trained in Oncology at St James’s University Hospital in Leeds.
His PhD was in immunology (immune reconstitution following high dose chemotherapy) and the research was at Leeds and at the National Cancer Institute in Amsterdam. He has been Clinical Director of Oncology and chair of the Oxford Cancer Directorate Therapeutics Committee and member of the Oxfordshire Cancer Treatment Panel. Also the lead clinician for testicular cancer with the Thames Valley Network.